drugset / Trial / NCT04212650
Losartan to Improve Hip Microfracture
Phase 1/2
Terminated
1 enrolled
Steadman Philippon Research Institute
Office of Naval Research (ONR) · collabUnited States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase I/IIA randomized, double-blind, placebo-controlled clinical trial to assess safety and efficacy of oral losartan for improving cartilage repair following microfracture to treat focal cartilage defects during hip arthroscopy.
Timeline
- Start
- 2020-08-07
- Primary completion
- 2020-12-04
- Completion
- 2020-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 12.5 mg | Oral |